Ticker

SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding Inc. Under the terms of this agreement, CBD Life Sciences Inc. has purchased 100% of the issued and outstanding stock of Mushroom Madness Inc. and Formrunner Apparel. This strategic acquisition ensures that both…

The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: Wellness products (oils, gummies, topicals) Medical uses (pain, anxiety, epilepsy) Increasing consumer acceptance and retail availability SCOTTSDALE, AZ / ACCESS Newswire / April 21, 2026 / CBD Life Sciences Inc. (OTC:CBDL)…

The natural, functional mushroom market is experiencing rapid growth, projected to exceed USD 60 billion by 2030, driven by rising demand for immunity-boosting, plant-based, and wellness products. Key trends include the dominance of Reishi, Lion's Mane, and Cordyceps in extracts and dietary supplements, alongside a high preference for locally sourced, fresh gourmet varieties.

With the global functional mushroom market projected to exceed $30+ billion and forecasted to grow at an estimated 9-12% CAGR, this strategic Bronx, New York distribution expansion positions CBDL to capture accelerating consumer demand, drive repeat retail velocity, and unlock scalable, high-margin revenue channels. SCOTTSDALE, ARIZONA / ACCESS Newswire / February 3, 2026 / CBD Life Sciences Inc. (OTC:CBDL), a…